Australia markets closed
  • ALL ORDS

    6,865.30
    +18.00 (+0.26%)
     
  • ASX 200

    6,634.10
    +18.80 (+0.28%)
     
  • AUD/USD

    0.7427
    -0.0013 (-0.17%)
     
  • OIL

    46.09
    +0.45 (+0.99%)
     
  • GOLD

    1,842.00
    +0.90 (+0.05%)
     
  • BTC-AUD

    25,696.04
    +41.42 (+0.16%)
     
  • CMC Crypto 200

    365.19
    -14.05 (-3.71%)
     
  • AUD/EUR

    0.6123
    +0.0001 (+0.02%)
     
  • AUD/NZD

    1.0529
    +0.0018 (+0.17%)
     
  • NZX 50

    12,631.38
    -17.53 (-0.14%)
     
  • NASDAQ

    12,528.48
    +61.35 (+0.49%)
     
  • FTSE

    6,550.23
    +59.96 (+0.92%)
     
  • Dow Jones

    30,218.26
    +248.74 (+0.83%)
     
  • DAX

    13,298.96
    +46.10 (+0.35%)
     
  • Hang Seng

    26,835.92
    +107.42 (+0.40%)
     
  • NIKKEI 225

    26,751.24
    -58.13 (-0.22%)
     

Company Profile for Guided Therapeutics, Inc.

·1-min read

Guided Therapeutics, Inc. (OTCQB: GTHP) has developed a rapid and painless testing platform for the early detection of disease based on its patented biophotonic technology that utilizes light to detect disease at the cellular level. The company’s first product, LuViva™, is a non-invasive device used to detect cervical disease instantly and at the point of care. In a multi-center clinical trial, with women at risk for cervical disease, LuViva was able to detect cervical cancer up to two years earlier than conventional tests. LuViva is designed to provide an objective result at the point-of-care, thereby improving the management of cervical disease: www.guidedinc.com.

Company:

Guided Therapeutics, Inc.

Headquarters Address:

5835 Peachtree Corners East

Suite B

Norcross, GA 30092

Main Telephone:

770-242-8723

Website:

www.guidedinc.com

Ticker/ISIN:

GTHP(OTCQB)/US40171F1057

Type of Organization:

Public

Industry:

Medical Devices

Key Executives:

CEO: Gene Cartwright

COO: Mark Faupel

Investor Relations

Contact:

Mark Faupel

Phone:

770-242-8723

Email:

mfaupel@guidedinc.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20201026005704/en/